ZIOPHARM Receives Notices of Allowance for European and US Patents

Wednesday, 20 August 2008

Via: ag-IP-news NEW YORK - ZIOPHARM Oncology Inc. announced in a press release that it has received notice from the European Patent Office that it intends to grant a patent with claims covering certain pharmaceutical formulations of indibulin (ZIO-301) for oral administration and processes for manufacturing such formulations. (Read more...)

Last Updated ( Friday, 22 August 2008 )